Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-03-01 @ 9:45 AM
Study NCT ID:
NCT03654768
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2018-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-29
First Submit QC Date:
None
Study First Post Date:
2018-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-26
Results First Submit QC Date:
None
Results First Post Date:
2025-12-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED